Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
BMC Cancer|January 8, 2025
Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinomaJeffrey Hiken, Jon Earls, Kevin C Flanagan, et al.The Journal of Molecular Diagnostics : JMD|February 10, 2020
Analytical Performance of an Immunoprofiling Assay Based on RNA ModelsIan Schillebeeckx, Jon R Armstrong, Jason T Forys, et al.Scientific Reports|January 26, 2022
T cell subtype profiling measures exhaustion and predicts anti-PD-1 responseIan Schillebeeckx, Jon Earls, Kevin C Flanagan, et al.Journal for Immunotherapy of Cancer|November 3, 2024
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT studyKevin C Flanagan, Jon Earls, Jeffrey Hiken, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsPeter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.European Urology Oncology|April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.Journal of Cancer Research and Clinical Oncology|August 8, 2023
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinomaKevin C Flanagan, Jon Earls, Ian Schillebeeckx, et al.Pageof 1